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Summary Unique and uncommon BamHI allelic restriction fragments of the Ha-ras locus have been
reported in the genomes of patients with cancer and of three affected members of a familial melanoma
kindred (Krontiris et al., 1986). Analysis of the BamHI and Msp/HpaII restriction fragments of peripheral
blood leucocyte DNA from the members of two families with hereditary melanoma (HM)/familial dysplastic
naevus syndrome (DNS) revealed that the only Ha-ras allele common to four affected members of one
kindred and two from a second kindred, was the 6.7kb allele which is found in 66% of the normal
population. This allele was found equally in affected and non-affected family members, and in one affected
case was inherited from an unaffected homozygous parent. It was absent in two affected sisters in a third
kindred. In the first kindred the karyotype of all three melanoma sufferers was 46XX 9qh +, while six
unaffected members had a normal karyotype. BamHI polymorphism of the Ha-ras gene does not identify the
affected members in the HM/DNS families studied.
A familial form of malignant melanoma has long
been recognised (Norris, 1820; Cawley, 1952) and
approximately 5% of melanoma patients have an
affected first degree relative (Anderson, 1971;
Scheibner et al., 1981). The closely related preneo-
plastic condition, familial dysplastic naevus
syndrome (DNS) (Greene et al., 1985b) and
hereditary melanoma (HM) itself probably
represent pleiotropic effects of a single highly
penetrant autosomal dominant gene (Greene et al.,
1985a). Although linkage analysis suggested a
possible link of the HM trait with the Rh locus on
the short arm of chromosome I (Greene et al.,
1983), analysis with several genetic markers (Greene
et al., 1983, 1985a), on lp have so far failed to
show close linkage.
The Harvey-ras oncogene on chromosome 11
displays BamHI restriction fragment length
polymorphism, ascribed to a region of variable
tandem repetition situated 3' to the coding
sequences (Goldfarb et al., 1982; Krontiris et al.,
1985). The disproportionate distribution of rare
alleles of the Harvey-ras oncogene amongst the
genomes of cancer patients, and the association of
one of these with three probands in a familial
melanoma kindred (Krontiris et al., 1985) led us to
a detailed analysis of a DNS/HM kindred in which
four affected members in two generations survived
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for analysis, and of the selected members of a
second kindred. We were unable to show any
linkage between melanoma occurrence and parti-
cular BamHI Ha-ras alleles.
Materials and Methods
The registry of familial melanoma in the Sydney
Melanoma Unit was searched for families in which
three or more affected members in two generations
were still living. The natural history of melanoma
makes the availability of such a related group a
rarity, and despite our large register of affected
families only three suitable kindreds were identified
of which one has been studied in detail. The
original excision biopsy specimens of affected
family members were reviewed by one histo-
pathologist (JG). The authenticity of the kindred
was established by paternity studies using blood
group phenotypes.
DNA was isolated from peripheral blood
leukocytes (Kunkel et al., 1977) yielding 0.4-
2.0mgDNA from 20ml heparinised venous blood.
Yields were 10-20% lower if the whole blood was
stored at -20°C before DNA isolation.
DNA (5gg) was digested separately with BamHI
and MspI/HpaII and the restriction fragments
fractionated respectively on 0.7% or 1.2% agarose
gels before transferring to nitrocellulose (Southern,
1975). The probe, a 6.6kb BamHI fragment
containing the EJ/T24 bladder carcinoma ras
oncogene cloned into pBR322 (Shih & Weinberg,
1982), was nick translated (Rigby et al., 1972) to a
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specific activity of 1-2 x 108 cpm,g-1. After hybri-
disation, filters were washed (0.1 x SSC) and
autoradiographed.
For cytogenetic studies, 0.5ml of whole blood
was added to 4.5ml medium (R.P.M.I. 1640+10%
v/v FCS, 1% v/v glutamine, 1% v/v gentamycin,
1.8% v/v phytohaemagglutinin). Cultures were
maintained for 72h at 37°C in lithium/heparin
tubes. Colchicine was added to a final concen-
tration of I ugml -1, 1 h prior to harvest. A
hypotonic solution of 0.075MKCI for 20min was
followed by fixation in several changes of 3:1
methanol: acetic acid. G-banding (Schweizer, 1980)
was performed on air-dried slides which had been
aged overnight at 60°C.
Ten G-banded cells were analysed for each
patient. If a heterochromatic variant was detected,
a further ten distamycin DAPI (Seabright, 1971)
stained cells were examined for confirmation.
Results
Preliminary Southern blotting experiments com-
paring peripheral blood leucocyte DNA from 33
normal controls, sporadic melanoma patients, and
isolated familial cases for whom affected relatives
were unavailable, confirmed polymorphism at the
Ha-ras locus for both MspI/HpaII and BamHI
restriction fragments. Restriction fragment lengths
and approximate allele frequency were as described
(Krontiris et al., 1985), but the four common alleles
(6.7kb, 7.1 kb, 7.8kb, and 8.3kb, Table I) and
several rarer alleles were equally represented in
melanoma patients and unaffected individuals with
Table I Size and frequency of BamHI
restriction fragment alleles of the Ha-ras
gene.
Allele Size Frequency
A 6.7 (6.9) 0.56 (0.66)
B 7.1 (7.5) 0.12 (0.11)
C 7.8 (8.0) 0.11 (0.09)
D 8.3 (8.3) 0.06 (0.07)
E 6.6 0.03
F 6.8 0.015
G 7.9 0.015
H 6.9 0.03
I 7.6 0.03
J 7.5 0.03
The frequency of BamH1 restriction
fragment alleles was determined in Ha-
ras-probed Southern blots of peripheral
blood DNA from 33 patients. Figures in
parentheses are taken from a population
study (Krontiris et al., 1985).
no family history of melanoma. We confirmed that
the differences in size between BamHI fragments
were identical to those between MspI fragments
(Krontiris et al., 1985), consistent with the region of
variability lying wholly within the MspI fragment.
When MspI and HpaII were used together the
restriction pattern was unaltered from that found
with MspI alone, indicating that methylation effects
were negligible.
Kindred I
We examined the Ha-ras restriction fragments from
16 members of an affected family spanning 4
generations (Figure 1). Included were three
members who had been surgically treated for
melanoma, and one member (111.3) who has
multiple dysplastic naevi, confirmed clinically and
histologically. Deceased individual 1.5 reportedly
had multiple large, irregularly shaped variegated
pigmented lesions and thus almost certainly also
had DNS. One spouse (111.5), with no family
history, has also had surgical excision of a
melanoma. Ha-ras-probed BamHI and MspI/HpaII
digests of genomic DNA from the family members,
are shown in Figure 2.
The restriction fragments are inherited in
Mendelian fashion and, as reported (Krontiris et
al., 1985) almost certainly represent alleles
of the c-Ha-ras gene. Within this family six Ha-ras
alleles are distinguishable. Upon digestion, these
generate a single fragment ranging from 1.0-2.7kb
(MspI/HpaII), or 6.6kb to 8.3kb (BamHI). Thus,
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Figure 1 Pedigree of kindred 1. Ha-ras alleles (Table
I) are indicated A-J. Living unaffected members 1.1,
11.4 and II.5 were not available for analysis.HARVEY-RAS IN FAMILIAL MELANOMA 789
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was 46XX 9qh+, while six unaffected family
members had a completely normal karyotype.
Kindred 2
Four members from a second family, three of
whom had histologically confirmed melanoma, were
also studied. All members had a normal karyotype.
The BamHI restriction fragment pattern and the
pedigree of this family are shown in Figure 3. There
is no Ha-ras allele that is common to the three
affected family members. This result was confirmed
for fragments generated by both BamHI and MspI.
1.1 1.2 1.3 1.4
8.3
6.6
6.7 kb
Figure 2 Southern blots of the same panel of WBC
DNAs of selected family members digested with MspI
(upper panel) and BamHI (lower panel). Individuals
are denoted by their pedigree position (see Figure 1). X
denotes affected individual; 111.3 has DNS.
heterozygotes have two bands and homozygotes a
single band. Resolution of different bands was
better with MspI digests.
The Ha-ras pedigree of this family is shown in
Figure 1. For simplicity we have lettered the alleles
A-J (Table I). In this family there is no rare Ha-ras
allele shared by affected members. The frequently
occuring A allele is the only allele common to all
affected members in this kindred. It also occurs in
individual 111.3 (DNS) and, by Mendelian
inference, in deceased individual 1.5 who almost
certainly also had DNS. This allele generates an
MspI fragment of 1.Okb and a BamHI fragment of
6.7kb (e.g. Figure 2, Lane 3). It corresponds to the
most common allele in the population with a
reported frequency of 66% (Table I). However,
even this common allele cannot have been co-
inherited with melanoma susceptibility from
individual 1.5 because the paternally inherited allele
in affected daughter 11.2 was B, not A (Figure 1).
Her mother (1.4), from whom the A allele was
inherited, is alive and well aged 82 and has no
evidence of melanoma or DNS.
The karyotype of all three melanoma patients
II
1 HJ
Figure 3 Pedigree and Ha-ras alleles of kindred 2
(BamHI). These genotypes have been confirmed by
MspI analysis. Alleles are designated A-J (Table I).
Discussion
The suggestion that BamHI RFLPs of the Ha-ras
gene might permit identification of at-risk members
of HM/DNS families (Krontiris et al., 1985)
prompted this study. In the first kindred, only one
Ha-ras allele common to all affected individuals
was found. This 'A' allele is found in two-thirds of
the normal population. In one affected family
member the A allele was inherited from an
unaffected homozygous parent, yet there is strong
evidence for a dominant mode of inheritance of the
melanoma trait (Greene et al., 1983). In the second
kindred there was no Ha-ras allele common to all790 C. SUTHERLAND et al.
affected individuals, although it is intriguing that
two of the affected members have rare alleles. The
two affected sisters in a limited third kindred were
genotype BB and BD (data not shown). We
conclude that BamHI polymorphism of the Ha-ras
oncogene does not identify the affected individuals
in the families studied and would not be of use in
their genetic counselling. Furthermore, linkage of
the melanoma trait with the common A allele is
highly unlikely.
Although extra copies of chromosome 9q have
been identified in human melanoma biopsy samples
(Wang & Pedersen, 1985), the 9qh+ found in
peripheral blood leuocytes in the three affected
members of one kindred is a common normal
karyotypic variant involving a heterochromatic
region near the centromere possibly involving the
tubulin genes (Craig-Holmes et al., 1973), and it is
therefore of doubtful significance. We are
continuing to collect DNA from HM/DNS
kindreds and to perform cytogenetic studies on
tumour biopsies from familial cases in order to
search for linkage to polymorphic loci possibly
involving chromosome lp (Greene et al., 1985a;
Dracopoli et al., 1985).
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